KPT-330 Prevents Aortic Valve Calcification via a Novel C/EBP β Signaling Pathway.

Conclusions: Our findings have met a critical need to discover alterative, pharmacological-based therapies in the treatment of CAVD. PMID: 33601919 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33601919?dopt=Abstract

Source: Circulation Research - February 19, 2021 Category: Cardiology Authors: Dutta P, Kodigepalli MK, LaHaye S, Thompson JW, Rains S, Nagel C, Thatcher K, Hinton RB, Lincoln J Tags: Circ Res Source Type: research